Role of Somatostatin Analogs in Pancreatic Neuroendocrine Tumors

Panelists discuss two clinical trials demonstrating that somatostatin analogs have an antiproliferative effect in patients with neuroendocrine tumors.

To view more from this conversation, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

• カテゴリー